Neurocognitive Correlates of the Influence of Number Word Syntax on Magnitude Processing
NUMWORD
1 other identifier
observational
84
1 country
1
Brief Summary
Linguistic irregularities in number naming systems, such as the inversion of number words, affect the processing of Arabic numerals. Recently, it has been claimed that there is even a syntactic representation of number words. participant investigate the neurofunctional correlates of the syntactic processing of number words by examining different levels of place-value processing in a study with two complementary successive phases (Group 1 and Group 2) in healthy adults. In the first phase with Group 1, participant evaluate the unit-decade compatibility effect (UDCE) in two-digit magnitude comparisons. In the second phase with Group 2, participant investigate the carry-over effect in two-digit addition problems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2025
CompletedFirst Posted
Study publicly available on registry
August 20, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2027
August 20, 2025
May 1, 2025
2.1 years
June 12, 2025
August 19, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Neurofunctional variables (fMRI)
the comparison of pairs of incompatible numbers compared to pairs of compatible numbers during the comparison of numbers.
Day 1
Structural variables (structural MRI)
the comparison of problems of addition with and without restraint during mental arithmetic.
Day 1
Behavioral variables,
we compare performance to the post-imaging reading test
Day 1
structural variables
recording of morphological and brain morphometric characteristics.
Day 1
Secondary Outcomes (2)
Handedness score
Day 1
Demographics questionnaire
Day 1
Study Arms (2)
Participants recruited (phase 1)
In each experimental phase (2 in total), 42 adult volunteers will be recruited (a total of 84 participants), selected based on the following criteria: * Aged 18-45 * Female or male * Right-handed * Signed informed consent * Normal medical, neurological, and neuroradiological examinations * Affiliated with a social security system * For women of childbearing age: under effective contraception; a urine pregnancy test will be administered * MRI examination compatible Participants will be recruited in the Paris region.
Participants recruited (phase 2)
In each experimental phase (2 in total), 42 adult volunteers will be recruited (a total of 84 participants), selected based on the following criteria: * Aged 18-45 * Female or male * Right-handed * Signed informed consent * Normal medical, neurological, and neuroradiological examinations * Affiliated with a social security system * For women of childbearing age: under effective contraception; a urine pregnancy test will be administered * MRI examination compatible Participants will be recruited in the Paris region.
Eligibility Criteria
In the experimental phase, 42 adult volunteers (a total of 84), selected according to strict criteria, will undergo an MRI scan, each comprising: - anatomical acquisition, - functional acquisition of activation during a number processing task (Phase 1: two-digit number magnitude comparison; Phase 2: multi-digit mental arithmetic).
You may qualify if:
- Subject aged 18 to 45 years;
- Female or male;
- Right-handed preference;
- Subject, or legal representative, who has given consent to participate;
- Native language: French
- Subject affiliated with a social security system;
- Having signed their consent to participate (and their legal representative if applicable),
- Subjects have read the information letter and given their free and informed consent;
- Normal medical, neurological, and neuroradiological examinations
- For women of childbearing age, be on effective contraception
You may not qualify if:
- Not corresponding to the targeted age range;
- Subject with contraindications to an MRI examination (pacemaker or neurosensory stimulator or implantable defibrillator, cochlear implants, ferromagnetic foreign bodies in the eyes or brain near neural structures, metal prostheses, patient agitation: non-cooperative or agitated patients, minors, claustrophobic subjects, pregnant women, ventriculoperitoneal neurosurgical shunt valves, dental braces);
- Subject with chronic alcohol or drug use;
- Abuse or dependence on substances (except nicotine) or toxic substances for more than 5 years or having led to comas (overdoses);
- Subject with sudden-onset cognitive disorders that could indicate a stroke; a history of head trauma with loss of consciousness for more than 1 hour, or encephalitis;
- Subject with chronic neurological, psychiatric, endocrine, hepatic, or infectious conditions;
- Subject with a history of major illness (diabetes, chronic lung disease, severe cardiac, metabolic, hematological, endocrine, or immunological disorder, cancer);
- Subject on medication: taking medications likely to interfere with brain imaging measurements (psychotropics, anxiolytic hypnotics, neuroleptics, anti-Parkinsonians, benzodiazepines, steroidal anti-inflammatories, antiepileptics, central analgesics, and muscle relaxants);
- Color blindness;
- Inability to comply with the study for geographical or psychiatric reasons;
- Tattoo incompatible with MRI;
- Cerebral palsy;
- Fine motor skills disorder;
- Adult subjects under legal protection or unable to give consent (article L.1121-8 of the French Public Health Code) (under guardianship or curatorship);
- Children and parents under legal protection measures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
GHU Ste Anne
Paris, 75014, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2025
First Posted
August 20, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 30, 2027
Last Updated
August 20, 2025
Record last verified: 2025-05